{
  "id": 4999824,
  "title": "Zepp Health Q2 2026 slides: revenue rises 7% as losses widen",
  "url": "https://urgent.news/2026/09/02/zepp-health-q2-2026-slides-revenue-rises-7-as-losses-widen",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-02T02:49:50.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/company-news/zepp-health-q2-2026-slides-revenue-rises-7-as-losses-widen-93CH-4885279"
  },
  "original_language": "en",
  "account": null,
  "summary": "Zepp Health reported a 7% rise in revenue for Q2 2026, reaching $64 million, but this growth was accompanied by widening losses, with adjusted net losses increasing to $12.5 million for the quarter and $30.5 million for the half-year. The company's shares dropped by 6.64% to $4.50 in regular trading before recovering slightly to $4.58 in after-hours trading, reflecting investor concerns about profitability despite the revenue increase. Zepp Health attributed the revenue growth to higher average selling prices and a focus on premium products, while operating expenses surged due to aggressive product launches. Despite supply constraints earlier in the year, revenue for Amazfit-branded wearables grew 6.9% year-over-year, reaching $64 million, but overall unit shipments decreased from 0.7 million to 0.6 million.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Seeking Alpha News",
        "title": "Zepp Health Non-GAAP EPADS of -$0.79, revenue of $63.53M; gives Q3 outlook",
        "url": "https://urgent.news/2026/09/02/zepp-health-non-gaap-epads-of-0-79-revenue-of-63-53m-gives-q3-outlook",
        "published": "2026-09-02T04:34:22.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}